Objectives: To develop a clinical prediction score for predicting mortality in children following return of spontaneous circulation after in-hospital cardiac arrest. Design: Observational study using prospectively collected data.
C ardiac arrest occurs in an estimated 16,000 children annually in the United States, with a higher rate of cases in the in-hospital setting compared with the outof-hospital setting (1, 2) . Although a number of clinical models exist for predicting mortality following in-hospital cardiac arrest in adult patients (3) (4) (5) (6) (7) , there is a paucity of clinically useful models to predict outcomes for children with return of spontaneous circulation (ROSC) after in-hospital cardiac arrest.
Using a United States-based national registry, Chan et al (4) recently developed a model to predict favorable neurologic outcome in adult patients successfully resuscitated from in-hospital cardiac arrest. The Cardiac Arrest Survival PostResuscitation In-Hospital score joined other models as ways to predict outcomes after adult in-hospital cardiac arrest, including the Good Outcomes Following Attempted Resuscitation score (5), the Prearrest Morbidity score (6) , and the Prognosis After Resuscitation score (7) . Prediction models provide outcome estimates for individual patients, help physicians provide prognostic information for family members, allow for stratification across hospitals to compare outcomes for quality improvement initiatives, and might be useful for patient stratification in clinical trials.
The aim of the current study was to develop a clinical prediction score for predicting mortality in children following ROSC after in-hospital cardiac arrest.
MATERIALS AND METHODS

Study Design and Data Source
This study is an analysis using data from the Get With The Guidelines-Resuscitation (GWTG-R) registry. The GWTG-R is a national, prospective, quality improvement registry of in-hospital cardiac arrest patients, sponsored by the American Heart Association. In the GWTG-R registry, cardiac arrest is defined as no pulse or a pulse with inadequate perfusion requiring chest compressions, defibrillation, or both, with a hospital-wide or unit-based emergency response by acute care personnel. Data are collected on all patients with a cardiac arrest without a do-not-resuscitate order. The design, data collection, and reliability of the GWTG-R registry have been described in detail elsewhere (8, 9) . In this study, we included data from January 1, 2000, to December 31, 2015. All participating hospitals are required to comply with local regulatory guidelines. Because data are used primarily at the local site for quality improvement, sites are granted a waiver of informed consent. The GWTG-R registry is deidentified, and the use in research in the absence of any other identifiable subject data does not meet the definition of human subject research.
Study Population
We included pediatric patients (< 18 yr old) with an index cardiac arrest and greater than or equal to 1 minute of documented chest compressions who achieved ROSC, defined as a palpable pulse without chest compressions for at least 20 minutes. We included patients with a loss of pulse and without a loss of pulse at the onset of chest compressions (e.g., patients receiving chest compressions for poor perfusion). We excluded patients for whom the event occurred in the delivery room or in the neonatal ICU and patients in whom cardiopulmonary bypass (e.g., extracorporeal cardiopulmonary resuscitation [E-CPR]) was employed during the event, as these events differ substantially from other cardiac arrests (10) . Furthermore, patients with missing data on included covariates and in-hospital mortality were excluded for the primary analysis.
Outcome and Predictor Variables
The primary outcome was in-hospital mortality. The secondary outcome was neurologic outcome at hospital discharge measured by the Pediatric Cerebral Performance Category (PCPC) score (11) , as recommended by the Utstein guidelines (12) . A PCPC score of 1 indicates no neurologic deficit; 2, mild cerebral disability; 3, moderate cerebral disability; 4, severe cerebral disability; 5, coma or vegetative state; and 6, brain death. A PCPC score of 1 or 2 was considered a favorable neurologic outcome, and a PCPC score from 3 to 6 or death was considered an unfavorable neurologic outcome. To account for alternative definitions of unfavorable neurologic outcome in pediatric cardiac arrest patients, we performed sensitivity analyses using the following definitions: 1) a PCPC score of 3, 4, 5, 6, or worse than baseline, 2) a PCPC score of 4, 5, or 6, and 3) a PCPC score of 4, 5, 6, or worse than baseline (13, 14) .
Predictor variables for the study outcome were selected a priori for model inclusion based on their potential relevance to in-hospital mortality and based on availability in the registry (9, (15) (16) (17) (18) . The full list of variables is presented in Table 1. Table S1 (Supplemental Digital Content 1, http:// links.lww.com/PCC/A587) provides a detailed description of pre-event characteristics, illness category, and interventions in place at the time of cardiac arrest.
Statistical Analysis
The cohort was divided at random into a derivation set (3/4 of the overall cohort) and validation set (1/4 of the overall cohort). Categorical variables are reported as counts with relative frequencies.
We created a list of potentially relevant clinical variables, which were entered in a multivariable logistic regression model in the derivation cohort. To account for correlations between patients within the same hospital, we used generalized estimation equations (GEEs) with an exchangeable covariance structure. Backward selection was used to sequentially (based on the highest p value) eliminate variables not significantly associated with the primary outcome (at a p < 0.05) or that did not improve overall model fit as determined by the Quasilikelihood under the Independence-model Criterion statistic (19) . A clinical prediction score was then created by assigning weighted points proportional to the B-coefficient values from the remaining variables in the parsimonious model, such that a higher point represented an increased risk of in-hospital mortality. Categories with similar B-coefficients (i.e., categories (4) 48 (4) Pulseless electrical activity 985 (25) 336 (26) Asystole 760 (20) 212 (16) Never pulseless 1,837 (47) 651 (50) Duration of chest compressions (min) h 1 427 (11) 145 (11) 2-4 1,053 (27) 324 (25) 5-9 831 (21) 294 (23) 10-14 448 (12) 143 (11) 15-19 255 (7) 88 (7) 20-24 233 (6) 85 (7) 25-29 181 ( (28) 366 (28) Arterial catheter 1,044 (27) 387 (30) a All variables are reported as counts (frequencies). receiving the same score in the final model) within the same variable were collapsed for simplification. Discrimination (C-statistic) and calibration (comparison of predicted and actual mortality in deciles, the HosmerLemeshow test) were calculated for the full model and the parsimonious model in the derivation cohort and for the clinical score in both the derivation and validation cohorts. For the GEE models, the 95% CI for the C-statistic was estimated by bootstrapping 1,000 data sets using unrestricted random sampling.
Multiple imputation was conducted as a predefined sensitivity analysis to account for missing data. This analysis was conducted in the complete cohort with patients meeting all inclusion criteria and no exclusion criteria (i.e., combining the derivation and validation cohorts). Missing data on covariates and in-hospital mortality were imputed using the fully conditional specification method (20) . A total of 20 imputed datasets were created (21) . For each dataset, we calculated the C-statistic and Hosmer-Lemeshow statistic for the final prediction score. Given that our measure of discrimination (C-statistic) is not symmetrically distributed, does not follow a specific distribution, and is bounded by zero and one, we report the median C-statistic with the first and third quartiles to illustrate the distribution of the values over the imputed datasets (22) . A similar approach was used for the results of the Hosmer-Lemeshow test.
As a predefined sensitivity analysis, the discrimination and calibration of the final prediction score were also assessed for neurologic outcome. Sensitivity analyses were conducted with alternative definitions of neurologic outcome. To test the robustness of the model, we performed a number of post hoc analyses in the validation cohort including 1) only events within the past 5 years (2011-2015) to assess score performance in a more contemporary cohort, 2) only patients with a loss of pulse, 3) only patients without a loss of pulse, and 4) patients based on age (neonate, infant, child, or adolescent) to verify the applicability of the score in specific age groups.
The newborn illness category (i.e., being born on the current admission) was removed from the GWTG-R registry in 2015 leaving the categories medical-cardiac, medical noncardiac, surgical-cardiac, and surgical noncardiac. To confirm the future value of the score, we conducted two post hoc sensitivity analyses. First, we excluded patients classified as newborn from the validation cohort and reassessed the score. Second, we reclassified newborn as missing for the illness category variable and reran the multiple imputation analysis for the complete cohort. Using this approach, we essentially reclassified newborn into medical-cardiac, medical noncardiac, surgicalcardiac, or surgical noncardiac. SAS version 9.4 (SAS Institute, Cary, NC) was used for all analyses. No adjustments were made for multiple comparisons.
RESULTS
Patient Characteristics
The final cohort included 5,190 patients (Fig. 1) . Patient and event characteristics for the derivation cohort (n = 3,893) and validation cohort (n = 1,297) were similar ( Table 1 ). The median age was 7 months (quartiles, 28 d, 4 yr), and 44% were female. Of those with a pulseless rhythm, 85% had an initial nonshockable rhythm. The median duration of chest compressions was 7 minutes (quartiles, 3, 17). In-hospital mortality was 39%. The coefficients from the reduced model were assigned weighted points for the 17 variables independently associated with mortality ( Table 2 ). The scores ranged from 2 to 40 (theoretically from 0 to 54) ( Fig. 2A) with a median score of 13 (quartiles, 10, 18). Predictors of in-hospital mortality following ROSC included age, illness category, pre-event characteristics, arrest location, day of the week, nonshockable pulseless rhythm, duration of chest compressions, and interventions in place at time of arrest. The odds ratio for in-hospital mortality per unit increase in the final score was 1.22 (95% CI, 1.20-1.24; p < 0.001). The C-statistic for the final score was 0.77 (95% CI, 0.75-0.78) (Fig. 3A) . The Hosmer-Lemeshow goodness-offit test (p = 0.04) was nominally significant, but the expected versus observed mortality plot indicated good calibration ( Fig. 4A) . The score was separated into five categories (0-9, 10-14, 15-19, 20-24, and ≥ 25) and plotted against in-hospital mortality (Fig. 5A) . All scores showed a stepwise increase in mortality with an observed mortality of 12% (95% CI, 9-14%) for scores 0-9 and 84% (95% CI, 79-88%) for scores greater than or equal to 25. Figure S1A (Supplemental Digital Content 1, http://links.lww.com/PCC/A587) illustrates the mortality distribution in the raw score.
Derivation Cohort
Validation Cohort
The score ranged from 2 to 37 with a median score of 14 (quartiles, 11, 19) (Fig. 2B) in the validation cohort. The C-statistic was 0.77 (95% CI, 0.74-0.79) (Fig. 3B) . The Hosmer-Lemeshow goodness-of-fit test (p = 0.14) and expected versus observed mortality plot (Fig. 4B) remained indicative of good calibration with no meaningful discrepancy between the expected and observed outcomes. The scores in the validation cohort showed a similar stepwise increase in mortality as in the derivation cohort with an observed mortality of 14% (95% CI, 9-18%) for scores 0-9 and 86% (95% CI, 78-94%) for scores greater than or equal to 25 (Fig. 5B) . Figure S1B (Supplemental Digital Content 1, http://links.lww.com/PCC/ A587) illustrates the mortality distribution in the raw score.
Neurologic Outcome
One-thousand one-hundred eight patients from the validation cohort were included in the secondary analysis regarding neurologic outcome. Six-hundred thirty-eight patients (63%) had an unfavorable neurologic outcome defined as PCPC 3, 4, 5, 6, or death. The C-statistic for this outcome was 0.72 (95% CI, 0.69-0.75) with a Hosmer-Lemeshow goodness-of-fit p value of 0.25 indicating good calibration. The sensitivity analyses accounting for alternative definitions of neurologic outcome were similar and demonstrated discriminative power and calibration comparable to the primary definition. For more details, see Table S2 (Supplemental Digital Content 1, http:// links.lww.com/PCC/A587).
Missing Data
After performing multiple imputations for missing data, 6,506 patients were available for analysis. The results for the imputed datasets were similar to the primary analysis. The median C-statistic was 0.76 (quartiles, 0.76, 0.76) and the median p value from the Hosmer-Lemeshow goodness-of-fit test was 0.15 (quartiles, 0.08, 0.17).
Post hoc Sensitivity Analyses
The sensitivity analyses for different categories of patients (events within the past 5 yr, patients with a loss of pulse, patients without a loss of pulse, patients in predefined age groups, and patients without a newborn illness category) in the validation cohort demonstrated overall good discrimination and moderate calibration. For more details, see Table 
DISCUSSION
We developed and internally validated a prediction score for initial survivors of pediatric in-hospital cardiac arrest. The final score demonstrated good discrimination and calibration in both the derivation and validation cohorts. With higher scores, there was a stepwise increase in mortality with an observed mortality of less than 15% for scores 0-9 and greater than 80% for scores greater than or equal to 25.
To our knowledge, this is the first clinical prediction score for in-hospital mortality in children following ROSC after inhospital cardiac arrest. Jayaram et al (23) recently leveraged the GWTG-R registry to develop a model for predicting survival to hospital discharge in pediatric in-hospital cardiac arrest patients from 2000 to 2009. Their model provides institutions an opportunity to compare risk-adjusted survival outcomes within and between institutions. However, for several reasons, the model may have limited clinical applicability at the patient level. First, since the primary aim of their study was to assess hospital variation in cardiac arrest survival, they included both patients with and without ROSC. Successfully resuscitated cardiac arrest patients have significantly different patient characteristics and mortality rates compared with those who do not survive the initial event. Second, their model did not include patients without a loss of pulse, which is a common presentation in pediatric cardiac arrests (18, 24) . Third, they included patients who were rescued with E-CPR (cardiopulmonary bypass) (23) .
In our model, variables independently associated with pediatric in-hospital mortality were largely consistent with prior studies looking at individual risk factors. For example, pediatric in-hospital mortality vary depending on age with higher survival rates in lower age groups (16) . A first rhythm of pulseless electrical activity or asystole has been associated with higher mortality rates compared with ventricular fibrillation or pulseless ventricular tachycardia (9) . Cardiac arrest secondary to trauma and malignancy has particularly high mortality rates, reflecting the overall poor prognosis associated with these conditions (24, 25) . A history of trauma and malignancy was relatively uncommon in our study (7% and 3%), and the high prediction score for these variables are therefore only applicable to a relatively small proportion of patients. Last, patients who arrest following cardiac surgery are known to have more favorable outcomes compared with those with a medical illness (15) . Other factors that might be associated with outcomes did not improve the predictive performance of our score, such as time of day of the arrest, certain pre-event characteristics, whether the event was witnessed or monitored, and whether antiarrhythmics were in place at the time of the cardiac arrest. Of note, we found pneumonia at the time of the event to be associated with decreased mortality. Although this might seem counterintuitive, cardiac arrests in pediatric patients frequently result from respiratory failure, which has been shown to have a better prognosis compared with other etiologies (26) . There was no difference in the prognosis for patients with shockable rhythms and patients without a loss of pulse in our model, although these estimates depend on what variables are included when developing the model and may be different in other settings (18) . The major distinctions between our pediatric model and the model developed by Chan et al (4) for adult patients using the GWTG-R registry were that certain pre-event characteristics (metabolic or electrolyte abnormality, pneumonia, acute nonstroke CNS event, and major trauma), the use of IV vasopressors, the day of the week, and the inclusion of patients without a loss of pulse were associated with mortality and included in the final score. Pediatric patients have different outcomes compared with adult patients, likely due to differences in etiology and pathophysiology (2, 27) . For example, pediatric events are frequently caused by respiratory failure and circulatory shock (28) , and the initial rhythm in pediatric patients are usually asystole or bradycardia (9), rather than asystole or pulseless electrical activity as seen in adult patients (29) . Both the pediatric and adult models found that higher age, nonshockable rhythms, duration of chest compressions, the use of mechanical ventilation, and certain pre-event characteristics (renal insufficiency, hepatic insufficiency, sepsis, malignancy, and hypotension) were negatively associated with outcomes.
Our study cohort included both patients with a loss of pulse and without a loss of pulse when chest compressions were initiated. Bradycardia with poor perfusion requiring chest compressions was the most frequent presentation, accounting for 50% of all rhythms at the time chest compressions were initially provided. Sensitivity analyses indicated that our score performed well in both populations. The positive but relatively weak relationship between a nonshockable rhythm and mortality might be explained by 1) our inclusion only of patients who survived the initial event and 2) because other variables potentially related to the initial rhythm, such as duration of cardiopulmonary resuscitation, were also included.
There are multiple postcardiac arrest variables, not collected by the GWTG registry, that may improve the clinician's ability to predict outcomes among children with ROSC. For example, multiple studies have found early electroencephalographic findings after successful resuscitation to be predictive of outcomes at hospital discharge (30) (31) (32) . Neurologic examination for motor and pupil response can be predictive of outcomes in pediatric patients undergoing therapeutic hypothermia post cardiac arrest (33) . Likewise, biomarkers including neuron specific enolase and S-100B can be predictive of both survival and neurologic outcomes (34) . Due to the nature of the data registry, our score did not include postcardiac arrest variables or quality of cardiopulmonary resuscitation metrics. Future models should aim to include these factors to potentially improve predictive performance.
We chose mortality as the primary outcome since this is the standard outcome measure for in-hospital cardiac arrest research (35) , and there was little missing data for this variable. Our final score also demonstrated good discrimination and calibration for unfavorable neurologic outcome and performed well for alternative definitions of unfavorable neurologic outcome.
Prediction scores may be useful for prognostication, research, and quality improvement. For example, a 1-month old patient who arrests in the PICU following cardiac surgery and survives after receiving chest compressions for 5 minutes will have a score of 8. On average, approximately 13% of patients with this score died prior to hospital discharge. This information may be useful for healthcare providers in providing prognostic information for patients and family members. The prediction score may also be used for stratifying patients in clinical trials by identifying low-, medium-, or high-risk patients who might be more or less likely to benefit from a given intervention. Last, the score could be used to compare outcomes among children with ROSC after in-hospital cardiac arrest across institutions while adjusting for baseline risk, as previously done by Jayaram et al (23) for all children with inhospital cardiac arrest (both those with and without ROSC).
Our results should be interpreted in the context of some study limitations. First, we had only access to in-hospital outcomes, and the predictive performance after hospital discharge remains unknown. Second, there were some missing data on neurologic outcome, and analyses related to this outcome should be interpreted with caution. Third, although the GWTG-R data are derived from a large number of hospitals within the United States, the performance of the score may be different for non-participating hospitals. Prospective external validation should be performed before use in the clinical setting. Fourth, given the constraints of the database, the score could not be compared with existing pediatric severity of illness scores. Finally, although the score showed good discrimination and calibration, we were not able to identify a group of patients with 100% mortality, and the score should not be used for individual withdrawal of care decisions.
CONCLUSIONS
We developed and internally validated a prediction score for initial survivors of pediatric in-hospital cardiac arrest. This prediction score may be useful for prognosticating following cardiac arrest, stratifying patients for research, and guiding quality improvement initiatives.
